Added to YB: 2025-10-29
Pitch date: 2025-10-27
WHWK [bullish]
Whitehawk Therapeutics, Inc.
-4.13%
current return
Author Info
Lionheart’s Newsletter is for presenting and discussing investment ideas in anything weird, obscure or underfollowed. I just want to turn over rocks and have fun! Sign up for the newsletter.
Company Info
Whitehawk Therapeutics, Inc., an oncology therapeutics company that develops technologies to establish tumor biology for cancer treatments.
Market Cap
$100.9M
Pitch Price
$2.42
Price Target
N/A
Dividend
N/A
EV/EBITDA
0.57
P/E
-6.90
EV/Sales
-4.29
Sector
Biotechnology
Category
value
International Markets, Dirt Cheap Solar Play and This Week's Bio-Tech Net Net - Whitehawk Therapeutics, Inc.
WHWK: Bio-tech net net w/ $168M net cash vs $110M market cap. Heavy cash burn $20-96M annually gives 1-2yr runway. 6mo options dropped 40% making them attractive vs 50% total loss risk. Basket approach for D-tier bio-techs trading below cash value.
Read full article (1 min)